Machines for Rnai
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Trans-Acting Antisense Rnas Mediate Transcriptional Gene Cosuppression in S
Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Trans-acting antisense RNAs mediate transcriptional gene cosuppression in S. cerevisiae Jurgi Camblong,1 Nissrine Beyrouthy, Elisa Guffanti, Guillaume Schlaepfer, Lars M. Steinmetz,2 and Francxoise Stutz3 Department of Cell Biology and NCCR ‘‘Frontiers in Genetics’’ Program, University of Geneva, 1211 Geneva 4, Switzerland Homology-dependent gene silencing, a phenomenon described as cosuppression in plants, depends on siRNAs. We provide evidence that in Saccharomyces cerevisiae, which is missing the RNAi machinery, protein coding gene cosuppression exists. Indeed, introduction of an additional copy of PHO84 on a plasmid or within the genome results in the cosilencing of both the transgene and the endogenous gene. This repression is transcriptional and position-independent and requires trans-acting antisense RNAs. Antisense RNAs induce transcriptional gene silencing both in cis and in trans, and the two pathways differ by the implication of the Hda1/2/3 complex. We also show that trans-silencing is influenced by the Set1 histone methyltransferase, which promotes antisense RNA production. Finally we show that although antisense-mediated cis-silencing occurs in other genes, trans- silencing so far depends on features specific to PHO84. All together our data highlight the importance of noncoding RNAs in mediating RNAi-independent transcriptional gene silencing. [Keywords: Antisense RNA; cis and trans transcriptional gene silencing; PHO84; cosuppression; RNAi-independent TGS; noncoding RNA; S. cerevisiae] Supplemental material is available at http://www.genesdev.org. Received January 15, 2009; revised version accepted May 18, 2009. Eukaryotic gene expression is a complex process regu- recently reported (Camblong et al. -
Engineering Nucleic Acid Chemistry for Precise and Controllable CRISPR
Science Bulletin 64 (2019) 1841–1849 Contents lists available at ScienceDirect Science Bulletin journal homepage: www.elsevier.com/locate/scib Review Engineering nucleic acid chemistry for precise and controllable CRISPR/Cas9 genome editing ⇑ Weiqi Cai a,b, Ming Wang a,b, a Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, CAS Research/Education Center for Excellence in Molecule Science, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China b University of Chinese Academy of Sciences, Beijing 100049, China article info abstract Article history: The clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (CRISPR/ Received 21 June 2019 Cas9) genome editing technology is revolutionizing our approach and capability to precisely manipulate Received in revised form 16 July 2019 the genetic flow of mammalians. The facile programmability of Cas9 protein and guide RNA (gRNA) Accepted 23 July 2019 sequence has recently expanded biomedical application of CRISPR/Cas9 technology from editing mam- Available online 30 July 2019 malian genome to various genetic manipulations. The therapeutic and clinical translation potential of CRISPR/Cas9 genome editing, however, are challenged by its off-target effect and low genome editing effi- Keywords: ciency. In this regard, developing new Cas9 variants and conditional control of Cas9/gRNA activity are of CRISPR/Cas9 genome editing great potential for improving genome editing accuracy and on-target efficiency. In this review, we sum- RNA engineering Nucleic acid chemistry marize chemical strategies that have been developed recently to engineer the nucleic acid chemistry of Gene therapy gRNA to enhance CRISPR/Cas9 genome editing efficacy, specificity and controllability. -
Distinct E-Cadherin-Based Complexes Regulate Cell Behaviour Through Mirna Processing Or Src and P120 Catenin Activity
ARTICLES Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity Antonis Kourtidis1, Siu P. Ngok1,5, Pamela Pulimeno2,5, Ryan W. Feathers1, Lomeli R. Carpio1, Tiffany R. Baker1, Jennifer M. Carr1, Irene K. Yan1, Sahra Borges1, Edith A. Perez3, Peter Storz1, John A. Copland1, Tushar Patel1, E. Aubrey Thompson1, Sandra Citi4 and Panos Z. Anastasiadis1,6 E-cadherin and p120 catenin (p120) are essential for epithelial homeostasis, but can also exert pro-tumorigenic activities. Here, we resolve this apparent paradox by identifying two spatially and functionally distinct junctional complexes in non-transformed polarized epithelial cells: one growth suppressing at the apical zonula adherens (ZA), defined by the p120 partner PLEKHA7 and a non-nuclear subset of the core microprocessor components DROSHA and DGCR8, and one growth promoting at basolateral areas of cell–cell contact containing tyrosine-phosphorylated p120 and active Src. Recruitment of DROSHA and DGCR8 to the ZA is PLEKHA7 dependent. The PLEKHA7–microprocessor complex co-precipitates with primary microRNAs (pri-miRNAs) and possesses pri-miRNA processing activity. PLEKHA7 regulates the levels of select miRNAs, in particular processing of miR-30b, to suppress expression of cell transforming markers promoted by the basolateral complex, including SNAI1, MYC and CCND1. Our work identifies a mechanism through which adhesion complexes regulate cellular behaviour and reveals their surprising association with the microprocessor. p120 catenin (p120) was identified as a tyrosine phosphorylation with this, E-cadherin is still expressed in several types of aggressive substrate of the Src oncogene1 and an essential component of the and metastatic cancer18–20. -
Not Dicer but Argonaute Is Required for a Microrna Production
Cell Research (2010) 20:735-737. npg © 2010 IBCB, SIBS, CAS All rights reserved 1001-0602/10 $ 32.00 RESEARCH HIGHLIGHT www.nature.com/cr A new twist in the microRNA pathway: Not Dicer but Argonaute is required for a microRNA production Gabriel D Bossé1, Martin J Simard1 1Laval University Cancer Research Centre, Hôtel-Dieu de Québec (CHUQ), Quebec City, Québec G1R 2J6, Canada Cell Research (2010) 20:735-737. doi:10.1038/cr.2010.83; published online 15 June 2010 Found in all metazoans, microRNAs A Canonical pathway B Ago2-dependent pathway or miRNAs are small non-coding RNA Nucleus Cytoplasm Nucleus Cytoplasm of ~22 nucleotides in length that com- Exp.5 Exp.5 pletely reshaped our understanding of gene regulation. This new class of gene pre-miR-451 regulator is mostly transcribed by the pre-miRNA RNA polymerase II producing a long stem-loop structure, called primary- or Ago2 pri-miRNA, that will first be processed Ago2 Dicer in the cell nucleus by a multiprotein TRBP complex called microprocessor to gen- erate a shorter RNA structure called Ago2 RISC precursor- or pre-miRNA. The precisely Ago2 RISC processed pre-miRNA will next be ex- ported into the cytoplasm by Exportin 5 and loaded onto another processing machine containing the ribonuclease III enzyme Dicer, an Argonaute protein Ago2 Ago2 and other accessory cellular factors mRNA mRNA (Figure 1A; [1]). Dicer will mediate the Translation inhibition Translation inhibition cleavage of the pre-miRNA to form the mature miRNA that will then be bound Figure 1 (A) Canonical microRNA biogenesis. In mammals, the pre-miRNA is by the Argonaute protein to form, most loaded onto a multiprotein complex consisting minimally of Dicer, Tar RNA Bind- likely with other cellular factors, the ef- ing Protein (TRBP) and Ago2. -
Exploring the Structure of Long Non-Coding Rnas, J
IMF YJMBI-63988; No. of pages: 15; 4C: 3, 4, 7, 8, 10 1 2 Rise of the RNA Machines: Exploring the Structure of 3 Long Non-Coding RNAs 4 Irina V. Novikova, Scott P. Hennelly, Chang-Shung Tung and Karissa Y. Sanbonmatsu Q15 6 Los Alamos National Laboratory, Los Alamos, NM 87545, USA 7 Correspondence to Karissa Y. Sanbonmatsu: [email protected] 8 http://dx.doi.org/10.1016/j.jmb.2013.02.030 9 Edited by A. Pyle 1011 12 Abstract 13 Novel, profound and unexpected roles of long non-coding RNAs (lncRNAs) are emerging in critical aspects of 14 gene regulation. Thousands of lncRNAs have been recently discovered in a wide range of mammalian 15 systems, related to development, epigenetics, cancer, brain function and hereditary disease. The structural 16 biology of these lncRNAs presents a brave new RNA world, which may contain a diverse zoo of new 17 architectures and mechanisms. While structural studies of lncRNAs are in their infancy, we describe existing 18 structural data for lncRNAs, as well as crystallographic studies of other RNA machines and their implications 19 for lncRNAs. We also discuss the importance of dynamics in RNA machine mechanism. Determining 20 commonalities between lncRNA systems will help elucidate the evolution and mechanistic role of lncRNAs in 21 disease, creating a structural framework necessary to pursue lncRNA-based therapeutics. 22 © 2013 Published by Elsevier Ltd. 24 23 25 Introduction rather than the exception in the case of eukaryotic 50 organisms. 51 26 RNA is primarily known as an intermediary in gene LncRNAs are defined by the following: (i) lack of 52 11 27 expression between DNA and proteins. -
RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases
G C A T T A C G G C A T genes Review RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases Amber Willbanks, Shaun Wood and Jason X. Cheng * Department of Pathology, Hematopathology Section, University of Chicago, Chicago, IL 60637, USA; [email protected] (A.W.); [email protected] (S.W.) * Correspondence: [email protected] Abstract: Chromatin structure plays an essential role in eukaryotic gene expression and cell identity. Traditionally, DNA and histone modifications have been the focus of chromatin regulation; however, recent molecular and imaging studies have revealed an intimate connection between RNA epigenetics and chromatin structure. Accumulating evidence suggests that RNA serves as the interplay between chromatin and the transcription and splicing machineries within the cell. Additionally, epigenetic modifications of nascent RNAs fine-tune these interactions to regulate gene expression at the co- and post-transcriptional levels in normal cell development and human diseases. This review will provide an overview of recent advances in the emerging field of RNA epigenetics, specifically the role of RNA modifications and RNA modifying proteins in chromatin remodeling, transcription activation and RNA processing, as well as translational implications in human diseases. Keywords: 5’ cap (5’ cap); 7-methylguanosine (m7G); R-loops; N6-methyladenosine (m6A); RNA editing; A-to-I; C-to-U; 2’-O-methylation (Nm); 5-methylcytosine (m5C); NOL1/NOP2/sun domain Citation: Willbanks, A.; Wood, S.; (NSUN); MYC Cheng, J.X. RNA Epigenetics: Fine-Tuning Chromatin Plasticity and Transcriptional Regulation, and the Implications in Human Diseases. Genes 2021, 12, 627. -
RNA Interference with Sirna
CANCER GENOMICS & PROTEOMICS 3: 127-136 (2006) Review RNA Interference with siRNA HELENA JOYCE*, ISABELLA BRAY* and MARTIN CLYNES National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland Abstract. Over the last decade, RNA interference has RNAs (13). Twenty-one different gene products with emerged as an effective mechanism for silencing gene different functions and subcellular localizations were expression. This ancient cellular antiviral response can be used studied. Knockdown experiments, monitored by to allow specific inhibition of the function of any chosen target immunofluorescence and immunoblotting, showed that even gene, including those involved in diseases such as cancer, major cellular proteins such as actin and vimentin could be AIDS and hepatitis. It has become an invaluable research tool silenced efficiently. Previous work had discovered that these to aid in the identification of novel genes involved in disease 22-nucleotide sequences served as guide sequences that processes. It has advanced from the use of synthetic RNA for instruct a multicomponent nuclease, RNA-induced silencing the endogenous production of small hairpin RNA by plasmid complex (RISC), to destroy specific messenger RNAs (7). and viral vectors, and from transient inhibition in vitro to It was then found that, in response to dsRNA, cells trigger longer-lasting effects in vivo. However, as with antisense and a two-step reaction. In the first step, long dsRNA is ribozymes, the efficient delivery of siRNA into cells is currently processed by a ribonuclease (RNase) III enzyme, called the limiting factor to successful gene expression inhibition in Dicer, into small interfering RNAs (siRNAs); these vivo. This review gives an overview of the mechanism of action subsequently serve as the sequence determinants of the of siRNA and its use in cancer research. -
Patenting Interfering RNA
Patenting Interfering RNA J. Douglas Schultz SPE Art Unit 1635 (571) 272-0763 [email protected] Oligonucleotide Inhibitors: Mechanisms of Action RNAi - Mechanism of Action • dsRNA induces sequence-specific degradation of homologous gene transcripts • RISC metabolizes dsRNA to small 21-23- nucleotide siRNAs – RISC contains dsRNase (“Dicer”), ssRNase (Argonaut 2 or Ago2) • RISC utilizes antisense strand as “guide” to find cleavable target siRNA Mechanism of Action miRNA Mechanism of Action Interfering RNA Glossary of Terms • RNAi – RNA interference • dsRNA – double stranded RNA • siRNA – small interfering RNA, double stranded, 21-23 nucleotides • shRNA – short hairpin RNA (doubled stranded by virtue of a ssRNA folding back on itself) • miRNA – micro RNA • RISC – RNA-induced silencing complex – Dicer – RNase endonuclease siRNA miRNA • Exogenously delivered • Endogenously produced • 21-23mer dsRNA • 21-23mer dsRNA • Acts through RISC • Acts through RISC • Induces homologous target • Induces homologous target cleavage cleavage • Perfect sequence match • Imperfect sequence match – Results in target degradation – Results in translation arrest RNAi Patentability issues Sample Claims: • A siRNA that inhibits expression of a nucleic acid encoding protein X. OR • A siRNA comprising a 2’-modification, wherein said modification comprises 2’-fluoro, 2’-O-methyl, or 2’- deoxy. (Note: no target recited) OR • A method of reducing tumor cell growth comprising administering siRNA targeting protein X. RNAi Patentability Issues 35 U.S.C. 101 – Utility • Credible/Specific/Substantial/Well Established. • Used to attempt modulation of gene expression in human diseases • Routinely investigate gene function in a high throughput fashion or to (see Rana RT, Nat. Rev. Mol. Cell Biol. 2007, Vol. 8:23-36). -
RNA Interference in the Nucleus: Roles for Small Rnas in Transcription, Epigenetics and Beyond
REVIEWS NON-CODING RNA RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond Stephane E. Castel1 and Robert A. Martienssen1,2 Abstract | A growing number of functions are emerging for RNA interference (RNAi) in the nucleus, in addition to well-characterized roles in post-transcriptional gene silencing in the cytoplasm. Epigenetic modifications directed by small RNAs have been shown to cause transcriptional repression in plants, fungi and animals. Additionally, increasing evidence indicates that RNAi regulates transcription through interaction with transcriptional machinery. Nuclear small RNAs include small interfering RNAs (siRNAs) and PIWI-interacting RNAs (piRNAs) and are implicated in nuclear processes such as transposon regulation, heterochromatin formation, developmental gene regulation and genome stability. RNA interference Since the discovery that double-stranded RNAs (dsRNAs) have revealed a conserved nuclear role for RNAi in (RNAi). Silencing at both the can robustly silence genes in Caenorhabditis elegans and transcriptional gene silencing (TGS). Because it occurs post-transcriptional and plants, RNA interference (RNAi) has become a new para- in the germ line, TGS can lead to transgenerational transcriptional levels that is digm for understanding gene regulation. The mecha- inheritance in the absence of the initiating RNA, but directed by small RNA molecules. nism is well-conserved across model organisms and it is dependent on endogenously produced small RNA. uses short antisense RNA to inhibit translation or to Such epigenetic inheritance is familiar in plants but has Post-transcriptional gene degrade cytoplasmic mRNA by post-transcriptional gene only recently been described in metazoans. silencing silencing (PTGS). PTGS protects against viral infection, In this Review, we cover the broad range of nuclear (PTGS). -
RNA Stem Structure Governs Coupling of Dicing and Gene Silencing in RNA
RNA stem structure governs coupling of dicing and PNAS PLUS gene silencing in RNA interference Hye Ran Koha,b,1, Amirhossein Ghanbariniakia,c,d, and Sua Myonga,c,d,1 aDepartment of Biophysics, Johns Hopkins University, Baltimore, MD 21218; bDepartment of Chemistry, Chung-Ang University, Seoul 06974, Korea; cInstitute for Genomic Biology, University of Illinois, Urbana, IL 61801; and dCenter for Physics of Living Cells, University of Illinois, Urbana, IL 61801 Edited by Brenda L. Bass, University of Utah School of Medicine, Salt Lake City, UT, and approved October 13, 2017 (received for review June 8, 2017) PremicroRNAs (premiRNAs) possess secondary structures consist- coworkers (20), but its relationship to the silencing efficiency has ing of a loop and a stem with multiple mismatches. Despite the not been tested. While the effect of mismatches between the well-characterized RNAi pathway, how the structural features of guide strand and target mRNA has been extensively studied (21– premiRNA contribute to dicing and subsequent gene-silencing 24), the effect of mismatch between guide and passenger strand efficiency remains unclear. Using single-molecule FISH, we dem- has not been systematically examined. onstrate that cytoplasmic mRNA, but not nuclear mRNA, is reduced We sought to study how different structural features found in during RNAi. The dicing rate and silencing efficiency both increase premiRNAs and presiRNAs modulate overall gene-silencing in a correlated manner as a function of the loop length. In contrast, efficiency by measuring two key steps in the RNAi pathway: (i) mismatches in the stem drastically diminish the silencing efficiency dicing kinetics to measure how quickly premiRNA or presiRNA without impacting the dicing rate. -
(12) Patent Application Publication (10) Pub. No.: US 2004/0086860 A1 Sohail (43) Pub
US 20040O86860A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0086860 A1 Sohail (43) Pub. Date: May 6, 2004 (54) METHODS OF PRODUCING RNAS OF Publication Classification DEFINED LENGTH AND SEQUENCE (51) Int. Cl." .............................. C12Q 1/68; C12P 19/34 (76) Inventor: Muhammad Sohail, Marston (GB) (52) U.S. Cl. ............................................... 435/6; 435/91.2 Correspondence Address: MINTZ, LEVIN, COHN, FERRIS, GLOWSKY (57) ABSTRACT AND POPEO, PC. ONE FINANCIAL CENTER Methods of making RNA duplexes and single-stranded BOSTON, MA 02111 (US) RNAS of a desired length and Sequence based on cleavage of RNA molecules at a defined position, most preferably (21) Appl. No.: 10/264,748 with the use of deoxyribozymes. Novel deoxyribozymes capable of cleaving RNAS including a leader Sequence at a (22) Filed: Oct. 4, 2002 Site 3' to the leader Sequence are also described. Patent Application Publication May 6, 2004 Sheet 1 of 2 US 2004/0086860 A1 DNA Oligonucleotides T7 Promoter -TN-- OR 2N-2-N-to y Transcription Products GGGCGAAT-N-UU GGGCGAAT-N-UU w N Deoxyribozyme Cleavage - Q GGGCGAAT -------' Racction GGGCGAAT N-- UU N-UU ssRNA products N-UU Anneal ssRNA UU S-2N- UU siRNA product FIGURE 1: Flowchart summarising the procedure for siRNA synthesis. Patent Application Publication May 6, 2004 Sheet 2 of 2 US 2004/0086860 A1 Full-length transcript 3'-digestion product 5'-digestion product (5'GGGCGAATA) A: Production of single-stranded RNA templates by in vitro transcription and digestion With a deoxyribozyme V 2- 2 V 22inv 22 * 2 &3 S/AS - 88.8x, *...* or as IGFR -- is as 4. -
The Excludon: a New Concept in Bacterial Antisense RNA-Mediated
Nature Reviews Microbiology | AOP, published online 24 December 2013; doi:10.1038/nrmicro2934 PROGRESS this paradigm in the context of other, better characterized asRNA-mediated regulatory The excludon: a new concept in mechanisms. The excludon concept describes unusually long asRNAs that inhibit the bacterial antisense RNA-mediated expression of one group of genes while enhancing the expression of a second group gene regulation of genes. Thus, single transcripts have the ability to control divergent operons that often have opposing functions. Nina Sesto, Omri Wurtzel, Cristel Archambaud, Rotem Sorek and Pascale Cossart asRNAs in microbial transcriptomes Abstract | In recent years, non-coding RNAs have emerged as key regulators of gene asRNAs are encoded on one strand of the DNA and overlap a gene that is encoded on expression. Among these RNAs, the antisense RNAs (asRNAs) are particularly the opposite strand. Therefore, these cis- abundant, but in most cases the function and mechanism of action for a particular encoded asRNAs have perfect complementa‑ asRNA remains elusive. Here, we highlight a recently discovered paradigm termed rity to the sense transcript from the opposite the excludon, which defines a genomic locus encoding an unusually long asRNA that DNA strand. The regulatory role of asRNAs spans divergent genes or operons with related or opposing functions. Because these was first reported more than 30 years ago, in the case of plasmid- and transposon-encoded asRNAs can inhibit the expression of one operon while functioning as an mRNA for asRNAs in Escherichia coli, when the asRNAs the adjacent operon, they act as fine-tuning regulatory switches in bacteria.